Top Gainers and Losers on November 28, 2025: M&M, Sun Pharma Lead Gains

Written by: Akshay ShivalkarUpdated on: 28 Nov 2025, 9:51 pm IST

Mixed sectoral trends kept the benchmark range bound as auto, and pharma stocks advanced while insurance counters slipped.

Top Gainers and Losers on November 28, 2025: M&M, Sun Pharma Lead Gains

The Nifty 50 closed nearly flat on November 28 at 26,202.95, down 12.60 points or 0.05%, as buying in auto and pharma names offset weakness in insurance and utilities. Mahindra & Mahindra (M&M), Sun Pharmaceutical Industries and Adani Enterprises led the gainers, while SBI Life, HDFC Life and Shriram Finance topped the losers list.

Top Gainers on Nifty 50

Company	Open (₹)	High (₹)	Low (₹)	LTP (₹)	% Change
Mahindra & Mahindra	3,692.00	3,768.90	3,690.10	3,761.00	2.17
Sun Pharma	1,810.30	1,833.00	1,807.50	1,832.00	1.20
Adani Enterprises	2,267.10	2,331.00	2,247.80	2,282.00	1.20
Kotak Mahindra Bank	2,119.00	2,141.80	2,102.20	2,125.10	0.71
Eicher Motors	6,999.00	7,065.00	6,956.00	7,045.00	0.66

Top Losers on Nifty 50

Company	Open (₹)	High (₹)	Low (₹)	LTP (₹)	% Change
SBI Life Insurance	2,011.00	2,011.10	1,961.00	1,970.00	-1.72
HDFC Life Insurance	780.40	780.40	761.45	767.20	-1.36
Shriram Finance	870.05	872.00	848.75	855.95	-1.35
Power Grid Corp	273.80	274.35	269.45	270.00	-1.35
Bharti Airtel	2,118.00	2,129.50	2,096.40	2,100.00	-0.74

Sectoral Trends

Auto and pharma sectors supported the index, while insurance and utilities dragged. Broader markets remained mixed, with midcaps and smallcaps showing limited movement.

Conclusion

Nifty 50 ended marginally lower on November 28 as gains in select auto and pharma stocks were offset by weakness in insurance and utilities. Market participants await GDP data and global cues for near-term direction, with volatility expected to remain subdued in the absence of major triggers.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Published on: Nov 28, 2025, 4:12 PM IST

Akshay Shivalkar

Akshay Shivalkar is a financial content specialist who strategises and creates SEO-optimised content on the stock market, mutual funds, and other investment products. With experience in fintech and mutual funds, he simplifies complex financial concepts to help investors make informed decisions through his writing.

Know More